Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-10 promoter polymorphism in psoriasis.

K Asadullah1, J Eskdale, A Wiese

  • 1Department of Dermatology, Medical School Charité, Humboldt University Berlin, Berlin, Germany. khusru.asadullah@schering.de

The Journal of Investigative Dermatology
|June 16, 2001
PubMed
Summary

Interleukin-10 (IL-10) gene variations are linked to familial psoriasis. The IL-10.G13 allele is more common in patients with a family history of psoriasis, especially those with early-onset disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Silicone granuloma from ruptured breast implants as a cause of cervical lymphadenopathy.

Annals of the Royal College of Surgeons of England·2016
Same author

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

Genes and immunity·2015
Same author

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

Genes and immunity·2014

Area of Science:

  • Genetics
  • Immunology
  • Dermatology

Background:

  • Interleukin-10 (IL-10) is a key cytokine in psoriasis.
  • The IL-10 promoter exhibits significant polymorphism, with microsatellites IL-10.G and IL-10.R being informative markers.
  • Understanding IL-10's role in psoriasis susceptibility is crucial for genetic research.

Purpose of the Study:

  • To investigate whether interleukin-10 (IL-10) promoter polymorphisms contribute to psoriasis susceptibility.
  • To analyze the distribution of IL-10.G and IL-10.R microsatellite alleles in psoriasis patients and healthy controls.
  • To determine if specific IL-10 alleles are associated with familial psoriasis or early disease onset.

Main Methods:

  • Genotyping of IL-10.G and IL-10.R microsatellite alleles in 78 psoriasis patients and 80 healthy controls.

Related Experiment Videos

  • Stratification of psoriasis patients based on age of onset (early vs. late) and family history.
  • Statistical analysis, including Chi-square tests and odds ratio calculations, to assess allele distribution differences.

    • Main Results:

    • No significant difference in IL-10.G and IL-10.R allele distribution was observed between psoriasis patients and controls.
    • A significant association was found between the IL-10.G locus and a positive family history of psoriasis (p = 0.04).
    • The IL-10.G13 allele was over-represented in familial psoriasis cases (40.4% vs. 19.6%), particularly in early-onset disease (<40 years).
    • Patients with the IL-10.G13 allele and early onset were four times more likely to have a family history of psoriasis (OR = 3.85).

    Conclusions:

    • The interleukin-10 (IL-10) locus contributes to the heritability of psoriasis susceptibility.
    • The IL-10.G13 allele is a potential genetic marker for familial and early-onset psoriasis.
    • Further research into IL-10's genetic influence on psoriasis pathogenesis is warranted.